Inversion of Left Ventricular Axial Shortening: In Silico Proof of Concept for Treatment of HFpEF.
Wolfgang Anton GoetzJiang YaoMichael BrenerRishi PuriMartin J SwaansSimon SchopkaSigrid WiesnerMarcus CreutzenbergHorst SievertGhassan S KassabPublished in: Bioengineering (Basel, Switzerland) (2024)
Left ventricular (LV) longitudinal function is mechanically coupled to the elasticity of the ascending aorta (AA). The pathophysiologic link between a stiff AA and reduced longitudinal strain and the subsequent deterioration in longitudinal LV systolic function is likely relevant in heart failure with preserved ejection fraction (HFpEF). The proposed therapeutic effect of freeing the LV apex and allowing for LV inverse longitudinal shortening was studied in silico utilizing the Living Left Heart Human Model (Dassault Systémes Simulia Corporation). LV function was evaluated in a model with (A) an elastic AA, (B) a stiff AA, and (C) a stiff AA with a free LV apex. The cardiac model simulation demonstrated that freeing the apex caused inverse LV longitudinal shortening that could abolish the deleterious mechanical effect of a stiff AA on LV function. A stiff AA and impairment of the LV longitudinal strain are common in patients with HFpEF. The hypothesis-generating model strongly suggests that freeing the apex and inverse longitudinal shortening may improve LV function in HFpEF patients with a stiff AA.
Keyphrases
- left ventricular
- cross sectional
- heart failure
- endothelial cells
- acute myocardial infarction
- blood pressure
- molecular docking
- mitral valve
- cardiac resynchronization therapy
- atrial fibrillation
- left atrial
- coronary artery disease
- coronary artery
- combination therapy
- aortic valve
- percutaneous coronary intervention
- molecular dynamics simulations
- catheter ablation